Hemodialysis (HD) has improved the prospects of. Sonoclot Analysis in Cardiac Surgery in Dialysis- Dependent Patients
|
|
- Aubrie Gallagher
- 5 years ago
- Views:
Transcription
1 CARDIOVASCULAR Sonoclot Analysis in Cardiac Surgery in Dialysis- Dependent Patients Toshihiko Shibata, MD, PhD, Yasuyuki Sasaki, MD, PhD, Koji Hattori, MD, PhD, Hidekazu Hirai, MD, Mitsuharu Hosono, MD, PhD, Hiromichi Fujii, MD, PhD, and Shigefumi Suehiro, MD, PhD Department of Cardiovascular Surgery, Osaka City University Medical School, Osaka, Japan Background. Dialysis-dependent patients have multiple disorders of hemostasis; however, there are no reports of viscoelastic changes during cardiac surgery in such patients. Methods. Hemostasis in dialysis-dependent patients during cardiac operations was evaluated. Thirty patients who underwent cardiopulmonary bypass (CPB) were studied: 6 with chronic renal failure undergoing dialysis (HD group), and 24 without hemodialysis. Blood samples were obtained at four points: before sternotomy, 30 and 90 minutes after the start of CPB, and after protamine administration. Results. Activated clotting time (ACT) measured with Sonoclot analyzer was significantly correlated with ACT measured traditionally (r 0.92; p < 0.001; y x). Values for ACT measured with Sonoclot analyzer as well as traditional ACT increased significantly during CPB. Values for ACT measured with Sonoclot analyzer in the HD group were significantly longer than those in the control group. Before CPB, both ACT measured with Sonoclot analyzer and traditional ACT in the HD group were significantly longer than those in the control group; however, there were no significant differences in ACT measured with Sonoclot analyzer between the groups after CPB. Clot rates and peak signal values were significantly decreased during CPB in both groups, and returned to preoperative values after protamine administration. There were no significant differences in clot rate and peak signal values between the two groups. There were no differences between the two groups in changes of time to peak. Platelet counts in the HD group were significantly higher (p < 0.05) than those in the control group. There were no differences in platelet counts after CPB between the two groups. Antithrombin III levels decreased below 50% during and after CPB. Antithrombin III in the HD group was significantly lower (p < 0.01) than those in the control group. A significant time-group interaction was observed in antithrombin III levels. Conclusions. Sonoclot signatures in HD patients showed no significant differences in viscoelastic changes compared with non-hd patients. (Ann Thorac Surg 2004;77:220 5) 2004 by The Society of Thoracic Surgeons Hemodialysis (HD) has improved the prospects of long-term survival for renal failure patients, and the number having cardiac operations has increased with lower perioperative mortality [1, 2]. Dialysis-dependent patients have multiple disorders of hemostasis [3, 4]. Cardiac surgeons have empirically recognized that hemostatic disorders are serious problems in patients undergoing dialysis [5]. The incidence of reexploration in such patients because of bleeding is higher [6, 7], leading to postoperative complications [8]. Aprotinin [9] and heparin-coated cardiopulmonary bypass (CPB) circuits [10] are reported to reduce postoperative bleeding and reexploration in dialysis patients. Although postoperative bleeding has been recognized as a common problem with cardiac surgery in dialysis-dependent patients, there are few studies of perioperative hemostasis and coagulofibrinolysis. During CPB large amounts of heparin are required for Accepted for publication Aug 1, Address reprint requests to Dr Shibata, Department of Cardiovascular Surgery, Osaka City University Medical School, 1-4-3, Asahi-machi, Abeno, Osaka , Japan; shibata@msic.med.osaka-cu.ac.jp. anticoagulation, and activated clotting time (ACT) has been used as an on-site monitor of anticoagulation. Activated clotting time measurement, although easy and reliable, does not reflect platelet function, but traditional laboratory coagulation tests are impractical because they are time-consuming. Accordingly, the use of on-site coagulation monitoring helps physicians more appropriately manage this during and after CPB. Sonoclot analysis, a viscoelastic measurement using a Sonoclot analyzer (Sienco Inc, Wheat Ridge, CO), offers a global assessment of whole blood clotting within 30 minutes [11, 12] and has shown its usefulness for evaluating intraoperative hemostatic changes [13]. Viscoelastic changes in blood have been measured by thromboelastograph; however, a Sonoclot analyzer can measure them with less intrusion. Viscoelastic changes of blood using a Sonoclot analyzer have not been reported during cardiac surgery involving dialysis patients. We assumed that dialysis patients have some differences in their viscoelastic and other coagulofibrinolytic variables during and after CPB. Thus, in this study we compared the viscoelastic changes in dialysis-dependent 2004 by The Society of Thoracic Surgeons /04/$30.00 Published by Elsevier Inc doi: /s (03)
2 Ann Thorac Surg SHIBATA ET AL 2004;77:220 5 SONOCLOT ANALYSIS IN DIALYSIS PATIENTS Table 1. Subject Characteristics Variables HD Group (n 6) Control Group (n 24) p Value Operation CABG 4 15 Valvular surgery Male/female 5/1 20/ Age (y) Body weight (kg) BUN (mg/dl) Creatinine (mg/dl) Bleeding-time (min) a Data are expressed as the mean standard deviation. BUN blood urea nitrogen; CABG coronary artery bypass grafting; HD hemodialysis. patients against patients without HD during cardiac surgery. 221 extracorporeal ultrafiltration method was used during CPB in dialysis patients. Protamine sulfate was given to neutralize the heparin after discontinuation of CPB. Additional protamine was given when ACT was longer than the preoperative control value. Packed red blood cells were given when hemoglobin fell below 7 g/dl during CPB. Sonoclot Analysis Sonoclot measures the viscoelastic drag of an oscillating Sono-probe, producing a graph called the Sonoclot signature (Fig 1). For Sonoclot analysis, blood samples (0.4 ml) were placed in the cuvette, which contains a high concentration of activator. The vibrating probe is immersed in the sample cuvette. The onset time (SonACT) is the time until the beginning of fibrin formation; this liquid phase of blood corresponds to the ACT. The rate of fibrin formation (clot rate) is indicated by the primary slope, and is expressed as a percentage of the peak CARDIOVASCULAR Patients and Methods Thirty patients who underwent elective cardiac surgery gave informed consent to be enrolled in this study, which had been approved by our hospital s institutional review board. Six dialysis-dependent patients with chronic renal failure underwent a cardiac operation with CPB (HD group). In the same period, 24 patients not presenting renal failure were chosen for the control group. The renal patients had been dialyzed for between 1 and 20 years (median, 12 years). Preoperative exclusion criteria in the control group were a previous cardiac operation, renal dysfunction (serum creatinine 1.5 mg/dl), hepatic dysfunction, acute myocardial infarction, aspirin administration, and heparin infusion. No patients in either group needed an intraaortic balloon pump. The clinical characteristics of the patients are summarized in Table 1. There were no differences between the groups in age, sex, or preoperative bleeding times. Hemodialysis was performed the day before surgery on all HD patients. Surgery was performed on both groups through a midline sternotomy, by the same team of surgeons. All materials in the CPB circuit were coated with covalently bonded heparin (Carmeda Bioactive Surface; Medtronic Cardiopulmonary, Anaheim, CA). The membrane oxygenator (Maxima model CB 1380; Medtronic Cardiopulmonary) was also coated with Carmeda Bioactive Surface. Patients received an initial heparin dose of 300 IU/kg just before CPB. Before CPB was initiated, the ACT (Hemochron; International Technidyne, Inc, Edison, NJ) exceeded 400 seconds. The ACT was determined every 30 minutes during CPB, and additional heparin was given to maintain anticoagulation levels. In both groups, CPB was maintained with a perfusion rate of 2.8 L min 1 m 2 under moderate hypothermia (rectal temperature approximately 32 C). Cardiac arrest was induced by aortic cross-clamping followed by the infusion of cold blood cardioplegia. The Fig 1. Sonoclot signature before sternotomy (A) and during cardiopulmonary bypass (B). (SonACT activated clotting time measured by Sonoclot analyzer.)
3 CARDIOVASCULAR 222 SHIBATA ET AL Ann Thorac Surg SONOCLOT ANALYSIS IN DIALYSIS PATIENTS 2004;77:220 5 test. Two-way analysis of variance with repeated measures was used to evaluate the difference between groups and group time interaction. If analysis of variance revealed significant effects, Student s t test was used for each sample. Univariate regression analysis was used. Blood transfusion was expressed as median and range, and compared with the Mann-Whitney U test. All data were evaluated with computer software (StatView 5.0; Abacus Concepts, Berkeley, CA). A p value of less than 0.05 was considered significant. Fig 2. Correlation between activated clotting time measured traditionally (ACT) and by Sonoclot analyzer (SonACT). The dotted line represents the correlation in the hemodialysis (HD) group (n 24; r 0.96; p 0.001; y x) and the solid line represents the correlation in the control group (n 96; r 0.92; p 0.001; y x). amplitude per unit time (normal range, 15 to 45 signals/ min). An inflection point on the upstroke represents the start of the contraction of fibrin strands by the action of platelets. The secondary slope reflects further fibrinogenesis, fibrin polymerization, and platelet-fibrin interaction. Two variables can be obtained from the peak. The peak signal reflects the completion of fibrin formation. The time to peak amplitude is an index of the rate of conversion of fibrinogen to fibrin. A time to peak of less than 30 minutes is considered normal. A downward slope is produced after the peak because platelets induce further contraction of the completed clot as serum is squeezed out of the clot matrix. Results The SonACT was significantly correlated with the ACT in 120 measured points (r 0.92; p 0.001; y x). Significant correlation between SonACT and ACT was observed in each group (Fig 2). The SonACT as well as the ACT increased significantly during CPB (Table 2). In the analysis with two-way analysis of variance in repeated measures, values for SonACT in the HD group were significantly longer than those in the control group. There were no significant differences in ACT between the two groups. Before CPB, both SonACT and ACT in the HD group were significantly longer than those in the control group; however, there were no significant differences in SonACT in either group after CPB. Clot rates were significantly decreased during CPB in both groups (HD group, from 25 8 to signals/min; control group, from 28 9 to signals/min), and returned to preoperative values after protamine administration (Fig 3). Peak signal values were significantly decreased during CPB in both groups (HD group, from to signals; control group, from to signals), and returned to Blood Sampling Blood samples were obtained from a radial arterial catheter or the arterial side of the CPB circuit at four time points: before sternotomy, 30 and 90 minutes after the start of CPB, and 5 minutes after protamine administration. Hematocrit and platelet counts were measured with an automatic cell counter. Plasma was separated by centrifugation at 3,000 g for 10 minutes and stored at 20 C to measure fibrinogen, antithrombin III (AT-III), thrombin-antithrombin III complex (TAT), and plasmin- 2 plasmin inhibitor complex. No correction for hemodilution was performed. Data Analysis The data are expressed as the mean standard deviation. Comparisons of variables of patient characteristics between groups were performed using Student s t test. The discrete variables were compared with Fisher s exact Fig 3. Changes in clot rate. Data represent the mean standard deviation. (CPB30 and CPB90 30 and 90 minutes after the start of bypass; HD hemodialysis group; POST after protamine administration; PRE before sternotomy.)
4 Ann Thorac Surg SHIBATA ET AL 2004;77:220 5 SONOCLOT ANALYSIS IN DIALYSIS PATIENTS Fig 4. Changes in peak signal value. Data represent the mean standard deviation. (CPB30 and CPB90 30 and 90 minutes after the start of bypass; HD hemodialysis group; POST after protamine administration; PRE before sternotomy.) preoperative values after protamine administration (Fig 4). There were no significant differences in clot rate and peak signal values between the two groups. The time to peak was not estimated during CPB because of the prolonged SonACT with heparinization. There were no differences between the two groups in changes of time to peak (Fig 5). Blood transfusion during CPB was significantly greater in the HD group (mean, 9 units; range, 8 to 10 units) as compared with the control group (mean, 0 units; range, 0 to 6 units). There were no significant differences in hematocrit between the two groups, but significant time group interaction was detected (Table 2). Hematocrit in the HD group was significantly lower before operation, but higher after CPB because of more transfusions. Platelet counts in the HD group were significantly higher (p 0.05) than those in the control group. There were no differences in platelet counts after CPB between the two groups. Antithrombin III levels decreased below 50% during and after CPB. Antithrombin III in the HD group was significantly lower (p 0.01) than in the control group. A significant time group interaction was observed in AT- III. There were no significant differences between the two groups in fibrinogen levels. The TAT gradually increased during CPB, and the increase was prominent after protamine administration in both groups. There were no significant differences between the two groups in the changes in TAT. The changes in the plasmin- 2 plasmin inhibitor complex showed no significant difference between the two groups. 223 evaluated in cardiac surgery. Significant differences between the two groups, evaluated with two-way analysis of variance with repeated measures, were recognized only in SonACT, platelet counts, and AT-III in this study. We expected that some difference in Sonoclot signature between the groups would be recognized, especially after CPB. Unexpectedly, no significant differences between the two groups were recognized in any indices of Sonoclot signature after protamine administration. There are several reports of hemostatic management in cardiac surgery using a Sonoclot analyzer; however, detailed changes of Sonoclot signature during and after CPB were not mentioned [13 16]. Inasmuch as the typical changes in Sonoclot signature during cardiac surgery have not been recognized, we used 24 nondialysis patients to determine accurate control values of the Sonoclot indices. This is why the number of patients was different between the two groups. The SonACT reflects the beginning of fibrin clot formation, and is thought to be a similar measurement as ACT measured with Hemochron. Actually, in the present study, SonACT and ACT had excellent correlation. This correlation was recognized in each group as well. When comparing the two groups, values for SonACT in dialysis patients were longer than those in the control group, but not ACT. Because the same dose of heparin was used in each group, no differences between the two groups should be detected in ACT and SonACT. Moreover, our data demonstrated significantly lower levels of AT-III in dialysis patients. Because AT-III plays an important role in anticoagulation with heparin, decreased preoperative CARDIOVASCULAR Comment In this study, changes in the Sonoclot signature and in coagulofibrinolytic markers of dialysis patients were Fig 5. Time to peak. Data represent the mean standard deviation. (HD hemodialysis group; POST after protamine administration; PRE before sternotomy.)
5 CARDIOVASCULAR 224 SHIBATA ET AL Ann Thorac Surg SONOCLOT ANALYSIS IN DIALYSIS PATIENTS 2004;77:220 5 Table 2. Hematologic and Coagulofibrinolytic Data a Variable Group Pre CPB30 CPB90 Post Hematocrit (%) Control HD c b PLT ( 10 4 /mm 3 ) Control HD c c ACT (s) Control HD SonACT (s) Control HD c c AT III (%) Control HD c 33 5 a b FIB (mg/dl) Control HD TAT (ng/ml) Control HD PIC (ng/ml) Control HD a Data are expressed as the mean SD. b p c p 0.01 compared with control. ACT activated clotting time (Hemochron); AT-III antithrombin III; CPB30 and CPB90 30 and 90 minutes after the start of bypass; FIB fibrinogen; PIC plasmin- 2 plasmin inhibitor complex; PLT platelet; Post after protamine administration; Pre before sternotomy; SonACT activated clotting time measured with Sonoclot analyzer; TAT thrombin antithrombin III complex. AT-III levels cause reduced response to heparin [17]. Therefore the ACT and SonACT in dialysis patients would be shorter owing to lower AT-III levels. The mechanism of prolonged SonACT in dialysis patients cannot be explained with only AT-III levels in our study. Ebrest and Berkowitz [3] reviewed hemostasis in renal disease, and mentioned reduced coagulation factors levels. Some other factors might contribute to prolonged SonACT in dialysis patients. Our data demonstrated no significant differences between the two groups in other variables in the Sonoclot signature. The time to peak represents the duration from the start of measurement to the time of the highest Sonoclot signal. It can be divided into two parts: horizontal (SonACT) and a slope (Fig 1A). Because SonACT is extremely prolonged in the presence of large doses of heparin, the time to peak is greatly influenced by extremely prolonged SonACT (Fig 1B). Accordingly, we consider that the time to peak is a less valuable variable during CPB. Therefore, we compared this variable before and after protamine administration. Pivalizza and colleagues [18] measured the viscoelastic changes in uremic patients using a thromboelastograph and Sonoclot and demonstrated a high clot rate and low time to peak in uremic patients. Holloway and associates [19] showed hypercoagulability and high fibrinogen levels in dialysis patients, whereas our data showed no significant differences in fibrinogen levels. We compared the indices of the Sonoclot signature and coagulofibrinolytic variables (TAT and plasmin- 2 plasmin inhibitor complex). During CPB, TAT levels are gradually increased even when adequate heparin is used [20]. In our data, TAT continued to increase after initiation of CPB, and the patterns of the changes in TAT levels were similar in both groups. Significant increases of TAT were noted after protamine administration in both groups, but no differences in TAT levels were observed between the two groups at any point. There were no significant changes in plasmin- 2 plasmin inhibitor complex levels between the two groups. These changes of coagulofibrinolytic variables were not likely to affect the Sonoclot signature. Another interest was whether dialysis patients actually have bleeding diathesis or not. Unfortunately we performed empiric platelet transfusion following blood sampling after protamine administration in some dialysis patients, but not in control patients. Therefore blood loss during operation could not be compared in this study. At any rate, the platelet transfusion in the HD group did not affect the data in this study. Platelet transfusion is often performed empirically in the management of bleeding, with little scientific basis. Although there are many available methods to determine platelet function [21], many of these are not suitable for care monitoring because they are time-consuming. The time to peak in Sonoclot signature is thought to correlate with general platelet function [14]. The present data showed that any significant changes between the two groups in the time to peak suggested that the platelet function was not aggravated after CPB in dialysis patients. Moreover, there were no differences in platelet counts between the two groups after CPB. These results suggest that empiric platelet transfusion should not be necessary in dialysis patients in respect to the quantity and function of the platelets. This study was limited because of the small number of patients and more transfusions during CPB in the HD group. Blood transfusion was inevitable in practice because dialysis patients generally have anemia. The Sonoclot signature in dialysis patients showed no significant
6 Ann Thorac Surg SHIBATA ET AL 2004;77:220 5 SONOCLOT ANALYSIS IN DIALYSIS PATIENTS differences in viscoelastic changes compared with nondialysis patients. From our study, we could not detect any significant evidence that dialysis patients were in bleeding diathesis. However, the fragility of vessels and tissue is another important factor in surgical bleeding, and further study is needed to reveal the hemostatic ability of dialysis patients in cardiac surgery. References 1. Nakamura Y, Sajata R, Ura M, Miyamoto TA. Coronary artery bypass grafting in dialysis patients. Ann Thorac Surg 1999;68: Frenken M, Krian A. Cardiovascular operations in patients with dialysis-dependent renal failure. Ann Thorac Surg 1999;68: Eberst ME, Berkowitz LR. Hemostasis in renal disease: pathophysiology and management. Am J Med 1994;96: Gordge MP, Faint RW, Rylance PB, et al. Platelet function and the bleeding time in progressive renal failure. Thromb Haemost 1988;60: Franza DL, Krata JM, Crumbley J, et al. Early and long-term results of coronary artery bypass grafting in dialysis patients. Ann Thorac Surg 2000;70: Moulton MJ, Creswell LL, Mackey ME, et al. Reexploration for bleeding is a risk factor for outcomes after cardiac operations. J Thorac Cardiovasc Surg 1996;111: Horst M, Mehlhorn U, Hoerstrup SP, et al. Cardiac surgery in patients with end-stage renal disease: 10-year experience. Ann Thorac Surg 2000;69: Durmaz I, Buket S, Atay Y, et al. Cardiac surgery with cardiopulmonary bypass in patients with chronic renal failure. J Thorac Cardiovasc Surg 1999;118: Lemmer JH, Metzdorff MT, Krause AH, et al. Aprotinin use 225 in patients with dialysis-dependent renal failure undergoing cardiac operation. J Thorac Cardiovasc Surg 1996;112: Suehiro S, Shibata T, Sasaki Y, et al. Cardiac surgery in patients with dialysis-dependent renal failure. Ann Thorac Cardiovasc Surg 1999;5: Hett DA, Walker D, Pilkington SN, et al. Sonoclot analysis. Br J Anaesth 1995;75: Lyew MA, Spaulding WC. Template for rapid analysis of the Sonoclot signature. J Clin Monit 1997;13: Tuman KJ, Spiess BD, McCarthy RJ, et al. Comparison of viscoelastic measures of coagulation after cardiopulmonary bypass. Anesth Analg 1989;69: Miyashita T, Kuro M. Evaluation of platelet function by Sonoclot analysis compared with other hemostatic variables in cardiac surgery. Anesth Analg 1998;87: Stern MP, DeVos-Doyle K, Viguera MG, Lajos TZ. Evaluation of post-cardiopulmonary bypass Sonoclot signatures in patients taking nonsteroidal anti-inflammatory drugs. J Cardiothorac Vasc Anesth 1989;3: Kamada Y, Yamakage M, Niiya T, Tsujiguchi N, Chen S, Namiki A. Celite-activated viscometer Sonoclot can measure the suppressive effect of tranexamic acid on hyperfibrinolysis in cardiac surgery. J Anesth 2001;15: Dietrich W, Brauin S, Spannagl M, Richter JA. Low preoperative antithrombin activity causes reduced response to heparin in adult but not in infant cardiac-surgical patients. Anesth Analg 2001;92: Pivalizza EG, Abramson DC, Harvey A. Perioperative hypercoagulability in uremic patients: a viscoelastic study. J Clin Anesth 1997;9: Holloway DS, Vagher JP, Caprini JA, et al. Thromboelastography of blood from subjects with chronic renal failure. Thromb Res 1987;45: Kumano H, Suehiro S, Hattori K, et al. Coagulofibrinolysis during heparin-coated cardiopulmonary bypass with reduced heparinization. Ann Thorac Surg 1999;68: Mackenzie ME, Gurbel PA, Levine DJ, Serebruany VL. Clinical utility of available methods for determining platelet function. Cardiology 1999;92: CARDIOVASCULAR
Cardiovascular surgery in patients on chronic dialysis: effect of intraoperative hemodialysis
Interactive Cardiovascular and Thoracic Surgery 3 (2004) 148 152 Institutional report - Cardiac general Cardiovascular surgery in patients on chronic dialysis: effect of intraoperative hemodialysis www.icvts.org
More informationThe increasing use of normothermic cardiopulmonary
A Prospective, Randomized Study of Cardiopulmonary Bypass Temperature and Blood Transfusion Paul E. Stensrud, MD, Gregory A. Nuttall, MD, Maria A. de Castro, MD, Martin D. Abel, MD, Mark H. Ereth, MD,
More informationHow can ROTEM testing help you in cardiac surgery?
How can ROTEM testing help you in cardiac surgery? Complicated bleeding situations can appear intra and post operatively. They can be life-threatening and always require immediate action. A fast differential
More informationComparison of Tranexamic Acid and Aminocaproic Acid in Coronary Bypass Surgery
Butler Journal of Undergraduate Research Volume 2 Article 24 2016 Comparison of Tranexamic Acid and Aminocaproic Acid in Coronary Bypass Surgery Lisa K. LeCleir Butler University, lisa.lecleir@gmail.com
More informationIntra-operative Effects of Cardiac Surgery Influence on Post-operative care. Richard A Perryman
Intra-operative Effects of Cardiac Surgery Influence on Post-operative care Richard A Perryman Intra-operative Effects of Cardiac Surgery Cardiopulmonary Bypass Hypothermia Cannulation events Myocardial
More informationISPUB.COM. Thrombelastography. O Wenker, Z Wojciechowski, R Sheinbaum, E Zisman INTRODUCTION PRINCIPLES OF THROMBELASTOGRAPHY
ISPUB.COM The Internet Journal of Anesthesiology Volume 1 Number 3 Thrombelastography O Wenker, Z Wojciechowski, R Sheinbaum, E Zisman Citation O Wenker, Z Wojciechowski, R Sheinbaum, E Zisman. Thrombelastography.
More informationDo Heparinase Thrombelastographs Predict Postoperative Bleeding?
Original Article Do Heparinase Thrombelastographs Predict Postoperative Bleeding? Paulla Mashburn BS, Jodie Ecklund BS, CCP, Jeffrey Riley BA, CCT, CCP Program in Extracorporeal Circulation Technology,
More informationIn patients undergoing cardiovascular operations, advanced
Risk Factor Analysis in Patients With Liver Cirrhosis Undergoing Cardiovascular Operations Akimasa Morisaki, MD, Mitsuharu Hosono, MD, Yasuyuki Sasaki, MD, Shoji Kubo, MD, Hidekazu Hirai, MD, Shigefumi
More informationTransfusion and Blood Conservation
Transfusion and Blood Conservation Kenneth G. Shann, CCP Assistant Director, Perfusion Services Senior Advisor, Performance Improvement Department of Cardiovascular and Thoracic Surgery Montefiore Medical
More informationThe Effects of Cardiopulmonary Bypass with Hollow Fiber Membrane Oxygenator on Blood Clotting Measured by Thromboelastography
Physiol. Res. 51: 145-150, 2002 The Effects of Cardiopulmonary Bypass with Hollow Fiber Membrane Oxygenator on Blood Clotting Measured by Thromboelastography M. HORÁČEK, K. CVACHOVEC Department of Anesthesiology
More informationIntraoperative application of Cytosorb in cardiac surgery
Intraoperative application of Cytosorb in cardiac surgery Dr. Carolyn Weber Heart Center of the University of Cologne Dept. of Cardiothoracic Surgery Cologne, Germany SIRS & Cardiopulmonary Bypass (CPB)
More informationTEG-Directed Transfusion in Complex Cardiac Surgery: Impact on Blood Product Usage
TEG-Directed Transfusion in Complex Cardiac Surgery: Impact on Blood Product Usage Kevin Fleming, CCP; Roberta E. Redfern, PhD; Rebekah L. March, MPH; Nathan Bobulski, CCP; Michael Kuehne, PhD, PA-C; John
More informationCardiopulmonary Support and Physiology
CSP Hemodilution and surgical hemostasis contribute significantly to transfusion requirements in patients undergoing coronary artery bypass Sandra Dial, MD, MSc, Eugene Delabays, MD, Martin Albert, MD,
More informationConventional CABG Or On Pump Beating Heart: A Difference In Myocardial Injury?
Conventional CABG Or On Pump Beating Heart: A Difference In Myocardial Injury? Kornelis J. Koopmans Medical Center Leeuwarden Leeuwarden, The Netherlands I have no disclosures Disclosures Different techniques
More informationCardiothoracic Fellow Expectations Division of Cardiac Anesthesia, Beth Israel Deaconess Medical Center
The fellowship in Cardiothoracic Anesthesia at the Beth Israel Deaconess Medical Center is intended to provide the foundation for a career as either an academic cardiothoracic anesthesiologist or clinical
More informationAlternative Anticoagulation during Cardiovascular Procedures in Pediatric Patients with Heparin-Induced Thrombocytopenia
The Journal of ExtraCorporeal Technology Alternative Anticoagulation during Cardiovascular Procedures in Pediatric Patients with Heparin-Induced Thrombocytopenia I. Ricardo Argueta-Morales, MD; Monica
More informationWithin coronary patients, those who are affected by
The Role of Antithrombin III in the Perioperative Management of the Patient With Unstable Angina Marco Rossi, MD, Lorenzo Martinelli, MD, Sergio Storti, MD, Michele Corrado, MD, Roberto Marra, MD Carmelita
More informationQuantitative Evaluation of Hypothermia, Hyperthermia, and Hemodilution on Coagulation
The Journal of The American Society of ExtraCorporeal Technology Quantitative Evaluation of Hypothermia, Hyperthermia, and Hemodilution on Coagulation Scott A. Kmiecik, MPS; Jun-Li Liu, MPS, MD, PhD; Tal
More informationModern Transfusion Management in Cardiovascular Surgery
Modern Transfusion Management in Cardiovascular Surgery Linda Shore-Lesserson, M.D. Professor of Anesthesiology Albert Einstein School of Medicine Montefiore Medical Center Bronx, New York Patient Blood
More informationPatients with chronic renal failure often have multiple
Prophylactic Dialysis in Patients With Renal Dysfunction Undergoing On-Pump Coronary Artery Bypass Surgery Isa Durmaz, MD, Tahir Yagdi, MD, Tanzer Calkavur, MD, Resad Mahmudov, MD, Anil Z. Apaydin, MD,
More informationBlood Management of the Cardiac Patient in the Postoperative Period
Blood Management of the Cardiac Patient in the Postoperative Period Al Stammers, MSA, CCP, Eric Tesdahl, PhD Andy Stasko MS, CCP, RRT, Linda Mongero, BS, CCP, Sam Weinstein, MD, MBA Goal To examine the
More informationThe Efficacy of Low Prime Volume Completely Closed Cardiopulmonary Bypass in Coronary Artery Revascularization
Original Article The Efficacy of Low Prime Volume Completely Closed Cardiopulmonary Bypass in Coronary Artery Revascularization Hideaki Takai, MD, Kiyoyuki Eishi, MD, Shiro Yamachika, MD, Shiro Hazama,
More informationPreoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery?
Preoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery? Damien J. LaPar MD, MSc, James M. Isbell MD, MSCI, Jeffrey B. Rich MD, Alan M. Speir MD, Mohammed
More informationThe Thromboelastogram and its Applications
Raja, Huening, Bradford, Lamphere November 2013 The Thromboelastogram and its Applications Overview: Blood products administration is an intravenous tissue transplant, in that cells or acellular components
More informationDo Sonoclot Coagulation Parameters Correlate with Thrombelastograph Parameters?
Original Article Do Sonoclot Coagulation Parameters Correlate with Thrombelastograph Parameters? Lem Meherg AS, RRT, Jeffrey B. Riley BA, CCT, Dennis R. Wolk RN, BS Program in Extracorporeal Circulation
More informationActivation of the Protein C System During Cardiopulmonary Bypass With and Without Aprotinin
Activation of the Protein C System During Cardiopulmonary Bypass With and Without Aprotinin Ron G. H. Speekenbrink, MD, Rogier M. Bertina, PhD, Francisco España, PhD, Charles R. H. Wildevuur, MD, PhD,
More informationCardiopulmonary Support and Physiology
Cardiopulmonary Support and Physiology Hemostatic effects of tranexamic acid in elective thoracic aortic surgery: A prospective, randomized, double-blind, placebo-controlled study Valter Casati, MD a Luca
More informationAndreas Koster, MD;* Roland Hansen, MD; Jürgen Schulz, PhD; Marian Kukucka, MD;* Thomas Fischer, MD;* Hermann Kuppe, MD
The Journal of The American Society of Extra-Corporeal Technology Assessment of the Resonance Thromboelastograph CS-3 for Differentiation of Coagulation Disorders: A Pilot in vitro Investigation of Simulated
More informationCardiac anaesthesia. Simon May
Cardiac anaesthesia Simon May Contents Cardiac: Principles of peri-operative management for cardiac surgery Cardiopulmonary bypass, cardioplegia and off pump cardiac surgery Cardiac disease and its implications
More informationRenal Failure after Coronary Bypass Surgery and the Associated Risk Factors
18 (1), 2015 [Epub February 2015] doi: 10.1532/hsf.1216 Online address: http://cardenjennings.metapress.com Renal Failure after Coronary Bypass Surgery and the Associated Risk Factors Hasan Reyhanoglu,
More informationAcute Kidney Injury after Cardiac Surgery: Incidence, Risk Factors and Prevention
Acute Kidney Injury after Cardiac Surgery: Incidence, Risk Factors and Prevention Hong Liu, MD Professor of Clinical Anesthesiology Department of Anesthesiology and Pain Medicine University of California
More informationAbstract. Introduction
Brazilian Journal of Medical and Biological Research (2006) 39: 63-69 Tranexamic acid and bleeding after cardiopulmonary bypass ISSN 0100-879X 63 A randomized, double-blind, and placebo-controlled study
More informationHemorrhagic complications of cardiac surgery represent
Factor V Leiden Protects Against Blood Loss and Transfusion After Cardiac Surgery Brian S. Donahue, MD, PhD; David Gailani, MD; Michael S. Higgins, MD, MPH; Davis C. Drinkwater, MD; Alfred L. George, Jr,
More informationECMO vs. CPB for Intraoperative Support: How do you Choose?
ECMO vs. CPB for Intraoperative Support: How do you Choose? Shaf Keshavjee MD MSc FRCSC FACS Director, Toronto Lung Transplant Program Surgeon-in-Chief, University Health Network James Wallace McCutcheon
More informationFibrinogen and Bleeding in Cardiac Surgery:
From the Department of Cardiovascular Surgery and Anesthesia Sahlgrenska University Hospital and Department of Molecular and Clinical Medicine Institute of Medicine, Sahlgrenska Academy University of Gothenburg
More informationAdvances in Transfusion and Blood Conservation
Advances in Transfusion and Blood Conservation Arman Kilic, MD Division of Cardiac Surgery, Department of Surgery, Johns Hopkins Hospital, Baltimore, MD No relevant financial relationships to disclose.
More informationChallenges in Perioperative. Coagulopathy in Elective and Urgent Cardiac Surgery
Challenges in Perioperative Hemostasis: Managing Coagulopathy in Elective and Urgent Cardiac Surgery Ian J. Welsby, MD, MBBS, FRCA Assistant Professor Department of Anesthesiology and Critical Care Duke
More informationNavigating the Dichotomies Between Literature and Your Clinical Practice
Navigating the Dichotomies Between Literature and Your Clinical Practice Robert Groom, CCP, FPP Cardiovascular Institute at Maine Medical Center Disclosures No relevant conflicts related to this presentation
More informationCABG in the Post-Aprotinin Era: Are We Doing Better? Ziv Beckerman, David Kadosh, Zvi Peled, Keren Bitton-Worms, Oved Cohen and Gil Bolotin
CABG in the Post-Aprotinin Era: Are We Doing Better? Ziv Beckerman, David Kadosh, Zvi Peled, Keren Bitton-Worms, Oved Cohen and Gil Bolotin DISCLOSURES None Objective(s): Our department routinely used
More informationIMPROVE PATIENT OUTCOMES AND SAFETY IN ADULT CARDIAC SURGERY.
Clinical Evidence Guide IMPROVE PATIENT OUTCOMES AND SAFETY IN ADULT CARDIAC SURGERY. With the INVOS cerebral/somatic oximeter An examination of controlled studies reveals that responding to cerebral desaturation
More informationRed Blood Cell Conservation A Surgeon s Journey. Goya V. Raikar MD FACS, FCCP Oklahoma Heart Hospital
Red Blood Cell Conservation A Surgeon s Journey Goya V. Raikar MD FACS, FCCP Oklahoma Heart Hospital Red Blood Cell Conservation Clinical impetus Evidence based learning Program development Industry partnerships
More informationWarm blood cardioplegia versus cold crystalloid cardioplegia for myocardial protection during coronary artery bypass grafting surgery
Nardi et al. Cell Death Discovery DOI 10.1038/s41420-018-0031-z Cell Death Discovery ARTICLE Warm blood cardioplegia versus cold crystalloid cardioplegia for myocardial protection during coronary artery
More informationEffects of protamine and heparin can be detected and easily differentiated by modified thrombelastography (Rotem Ò ): an in vitro study
British Journal of Anaesthesia 95 (3): 31 1 (5) doi:1.193/bja/aei197 Advance Access publication July 15, 5 Effects of protamine and heparin can be detected and easily differentiated by modified thrombelastography
More informationPharmacologic impairment of platelet membrane glycoprotein
Emergency Coronary Artery Bypass Graft Surgery in Abciximab-Treated Patients John H. Lemmer, Jr, MD, Mark T. Metzdorff, MD, Albert H. Krause, Jr, MD, M. Alan Martin, MD, J. Edward Okies, MD, and Jon G.
More informationPOSTOPERATIVE HEMORRHAGE in cardiac surgery is a
Increased Chest Tube Drainage Is Independently Associated With Adverse Outcome After Cardiac Surgery Michael C. Christensen, MSc, MPA, DrPH,* Frank Dziewior, MD, Angela Kempel, MSc, and Christian von Heymann,
More informationPreparing for Patients at High Risk of Transfusion
18/10/2017 Preparing for Patients at High Risk of Transfusion Jane Ottens. B.Sc., CCP ( Aust) Ashford Hospital, South Australia Preparing for Patients at High Risk of Transfusion Jane Ottens. B.Sc., CCP
More informationImpact of Preoperative Renal Dysfunction on Outcomes of Off-Pump Coronary Artery Bypass Grafting
Impact of Preoperative Renal Dysfunction on Outcomes of Off-Pump Coronary Artery Bypass Grafting Lokeswara Rao Sajja, MD, Gopichand Mannam, FRCS (CT), Rajasekara M. Chakravarthi, MD, Jyothsna Guttikonda,
More informationWarfarin Cessation Before Cardiopulmonary Bypass: Lessons Learned from a Randomized Controlled Trial of Oral Vitamin K
Warfarin Cessation Before Cardiopulmonary Bypass: Lessons Learned from a Randomized Controlled Trial of Oral Vitamin K Richard P. Whitlock, MD, Mark A. Crowther, MD, Theodore E. Warkentin, MD, Mary-Helen
More informationOriginal Article Post-Operative Bleeding Pak Armed Forces Med J 2014; 1(1): S13-18
Original Article Post-Operative Bleeding Pak Armed Forces Med J 2014; 1(1): S13-18 COMPARISON OF DIFFERENT DOSES OF TRANEXAMIC ACID ON POST-OPERATIVE BLEEDING IN PATIENTS OF CABG SURGERY Fakher-e-Fayaz,
More informationUniversity of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives
University of Florida Department of Surgery CardioThoracic Surgery VA Learning Objectives This service performs coronary revascularization, valve replacement and lung cancer resections. There are 2 faculty
More informationA Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery
A Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery Arman Kilic, MD 1, Rika Ohkuma, MD 1, J. Trent Magruder, MD 1, Joshua C. Grimm, MD 1, Marc Sussman, MD 1, Eric B. Schneider, PhD 1,
More informationCoronary Artery Bypass Graft: Monitoring Patients and Detecting Complications
Coronary Artery Bypass Graft: Monitoring Patients and Detecting Complications Madhav Swaminathan, MD, FASE Professor of Anesthesiology Division of Cardiothoracic Anesthesia & Critical Care Duke University
More informationEmergency surgery in acute coronary syndrome
Emergency surgery in acute coronary syndrome Teerawoot Jantarawan Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
More informationExcessive Bleeding After Cardiac Surgery in Adults: Reasons and Management
DOI: 10.2478/v10163-010-0017-2 ACTA CHIRURGICA LATVIENSIS 2009 (9 ) PROBLEM SOLVING ARTICLE Excessive Bleeding After Cardiac Surgery in Adults: Reasons and Management Agnese Ozolina*, Eva Strike*,**,Vladimirs
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL Table S1: Number and percentage of patients by age category Distribution of age Age
More informationADMINISTRATIVE CLINICAL Page 1 of 6
ADMINISTRATIVE CLINICAL Page 1 of 6 Anticoagulant Guidelines #2: REVERSAL OF OR MANAGEMENT OF BLEEDING WITH ANTICOAGULANTS Origination Date: Revision Date: Reviewed Date: 09/12 09/12, 01/13, 11/13, 11/15
More informationLow Dose versus High Dose Heparinization during Post Cardiotomy ECMO: A Case Control Study Disclosures Introduction
Low Dose versus High Dose Heparinization during Post Cardiotomy ECMO: A Case Control Study Vanessa Arnold, BS Mindy M Blackwell, MS, CCP Perfusion Technology Program College of Health Sciences Rush University
More informationOPCAB IS NOT BETTER THAN CONVENTIONAL CABG
OPCAB IS NOT BETTER THAN CONVENTIONAL CABG Harold L. Lazar, M.D. Harold L. Lazar, M.D. Professor of Cardiothoracic Surgery Boston Medical Center and the Boston University School of Medicine Boston, MA
More informationAprotinin Use in Cardiac Surgery Patients at Low Risk for Requiring Blood Transfusion
Aprotinin Use in Cardiac Surgery Patients at Low Risk for Requiring Blood Transfusion Judith L. Kristeller, Pharm.D., Russell F. Stahl, M.D., FACS, Brian P. Roslund, Pharm.D., and Marie Roke-Thomas, Ph.D.
More informationSafety of Heparin-Coated Circuits in Primates During Deep Hypothermic Cardiopulmonary Bypass
Original Article Safety of Heparin-Coated Circuits in Primates During Deep Hypothermic Cardiopulmonary Bypass Joseph j. Sistino, MPA, CCP, Robert E. Michler, MD, Linda B. Mongero, BS, CCP, Arthur Schwartz,
More informationRetrospective Study Of Redo Cardiac Surgery In A Single Centre. R Karthekeyan, K Selvaraju, L Ramanathan, M Rakesh, S Rao, M Vakamudi, K Balakrishnan
ISPUB.COM The Internet Journal of Anesthesiology Volume 12 Number 2 Retrospective Study Of Redo Cardiac Surgery In A Single Centre R Karthekeyan, K Selvaraju, L Ramanathan, M Rakesh, S Rao, M Vakamudi,
More informationThe Influence of Previous Percutaneous Coronary Intervention in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting
Original Article The Influence of Previous Percutaneous Coronary Intervention in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting Toshihiro Fukui, MD, Susumu Manabe, MD, Tomoki Shimokawa, MD,
More informationEffects of the Postoperative Administration of Diltiazem on Renal Function After Coronary Artery Bypass Grafting
Effects of the Postoperative Administration of Diltiazem on Renal Function After Coronary Artery Bypass Grafting Susumu Manabe, MD, Hiroyuki Tanaka, MD, PhD, Tomoya Yoshizaki, MD, Noriyuki Tabuchi, MD,
More informationIncreased postoperative blood loss after cardiac operations
Efficacy of Aprotinin, Epsilon Aminocaproic Acid, or Combination in Cyanotic Heart Disease Sandeep Chauhan, MD, Bisoi Akshay Kumar, MCh, Beeraka Heramba Rao, MD, Marigaddi Sanjeeva Rao, MCh, Bharat Dubey,
More informationTransfusion & Mortality. Philippe Van der Linden MD, PhD
Transfusion & Mortality Philippe Van der Linden MD, PhD Conflict of Interest Disclosure In the past 5 years, I have received honoraria or travel support for consulting or lecturing from the following companies:
More informationSredišnja medicinska knjižnica
Središnja medicinska knjižnica Petričević M., Biočina B., Boban M., Zrno Mihaljević M., White A., Rotim C., Subašić A., Miličić Davor. (2015) Clinical relevance and practical value of platelet function
More informationFresh and Citrated Whole-Blood Specimens Can Produce Different Thromboelastography Results in Patients on Extracorporeal Membrane Oxygenation
Fresh and Citrated Whole-Blood Specimens Can Produce Different Thromboelastography Results in Patients on Extracorporeal Membrane Oxygenation Elizabeth A. Gilman, MD, 1 Christopher D. Koch, 1 Paula J.
More informationPreoperative Serum Bicarbonate Levels Predict Acute Kidney Iinjry after Cardiac Surgery
International Journal of ChemTech Research CODEN (USA): IJCRGG, ISSN: 0974-4290, ISSN(Online):2455-9555 Vol.11 No.06, pp 203-208, 2018 Preoperative Serum Bicarbonate Levels Predict Acute Kidney Iinjry
More informationGoals and Objectives. Assessment Methods/Tools
CA-2 CARDIOTHORACIC ANESTHESIA ROTATION Medical Center Fairview (UMMC) Rotation Site Director: Drs. Ioanna Apostolidou & Douglas Koehntop Rotation Duration: 6 weeks Introduction: The overall goal of the
More informationIs Renal Dysfunction a Risk Factor in Patients Undergoing Cardiac Surgery?: Mansoura Cardio Thoracic Unit Experience
ISPUB.COM The Internet Journal of Anesthesiology Volume 13 Number 1 Is Renal Dysfunction a Risk Factor in Patients Undergoing Cardiac Surgery?: Mansoura Cardio Thoracic Unit Experience N Mageed, Y El-Ghoniemy
More informationMayor lung resection in the presence of anti-platelet therapy. Hans-Beat Ris Service de Chirurgie Thoracique CHUV, Lausanne
Mayor lung resection in the presence of anti-platelet therapy Hans-Beat Ris Service de Chirurgie Thoracique CHUV, Lausanne THORACIC SURGERY IN THE PRESENCE OF ANTI-PLATELET THERAPY Charybdis: Thrombosis
More informationResults and Treatment Strategy for Patients Undergoing Emergent Coronary Artery Bypass Grafting
Original Article Results and Treatment Strategy for Patients Undergoing Emergent Coronary Artery Bypass Grafting Stefan Christiansen, MD, and Rüdiger Autschbach, MD Background: Emergent coronary artery
More informationPerioperative and Mid-Term Results of Coronary Bypass Surgery in Patients Undergoing Chronic Dialysis
Original Article Perioperative and Mid-Term Results of Coronary Bypass Surgery in Patients Undergoing Chronic Dialysis Tsuneo Ariyoshi, MD, Kiyoyuki Eishi, MD, Shiro Yamachika, MD, Shiro Hazama, MD, Hideaki
More informationDoes Coronary Artery Bypass Graft Surgery Improve Survival Among Patients With End-Stage Renal Disease?
Does Coronary Artery Bypass Graft Surgery Improve Survival Among Patients With End-Stage Renal Disease? Todd M. Dewey, MD, Morley A. Herbert, PhD, Syma L. Prince, RN, Carrie L. Robbins, RN, Christina M.
More informationCoatings: Are they really effective and how good is the evidence?
Coatings: Are they really effective and how good is the evidence? or is this another example of the Emperor s New Clothes? Richard Tallman, Ph.D. Associate Professor, Emeritus The Ohio State University
More informationHeparin-induced thrombocytopenia (HIT) is a severe
Bivalirudin During Cardiopulmonary Bypass in Patients With Previous or Acute Heparin-Induced Thrombocytopenia and Heparin Antibodies: Results of the CHOOSE-ON Trial Andreas Koster, MD, Cornelius M. Dyke,
More informationPerioperative coagulation management during cardiac surgery
REVIEW C URRENT OPINION Perioperative coagulation management during cardiac surgery Christian F. Weber, Matthias Klages, and Kai Zacharowski Purpose of review Cardiac surgery patients commonly present
More informationThromboelastography Use in the Perioperative Transfusion Management of a Patient with Hemophilia A Undergoing Liver Transplantation
Open Journal of Organ Transplant Surgery, 2013, 3, 13-17 http://dx.doi.org/10.4236/ojots.2013.31003 Published Online February 2013 (http://www.scirp.org/journal/ojots) Thromboelastography Use in the Perioperative
More informationCurrent status of antifibrinolytics in cardiopulmonary bypass and elective deep hypothermic circulatory arrest
Anesthesiology Clin N Am 21 (2003) 527 551 Current status of antifibrinolytics in cardiopulmonary bypass and elective deep hypothermic circulatory arrest Jeffrey A. Green, MD*, Bruce D. Spiess, MD Department
More information2012, Görlinger Klaus
Gerinnungsmanagement der Gegenwart - wie gehen wir heute vor? 25. Allander Gerinnungsrunde am 15. März 2012 Klaus Görlinger Universitätsklinikum Essen klaus@goerlinger.net CSL Behring GmbH Octapharma AG
More informationClinical Overview of Coagulation Testing Issues
Clinical Overview of Coagulation Testing Issues Adam M. Vogel, MD Assistant Professor, Division of Pediatric Surgery Washington University in St. Louis School of Medicine September 19, 2014 Disclosure
More informationErik J. Fransen, MSc, PhD; Jart H. C. Diris, MSc; Jos G. Maessen, MD, PhD; Wim Th. Hermens, PhD; Marja P. van Dieijen-Visser, MD, PhD
Evaluation of New Cardiac Markers for Ruling Out Myocardial Infarction After Coronary Artery Bypass Grafting* Erik J. Fransen, MSc, PhD; Jart H. C. Diris, MSc; Jos G. Maessen, MD, PhD; Wim Th. Hermens,
More informationSERUM MAGNESIUM LEVELS IN AORTIC AND MITRAL VALVE REPLACEMENT SURGERIES Srinivasa Rao Gondi 1, Venkata Sesha Sai Krishna Manne 2
SERUM MAGNESIUM LEVELS IN AORTIC AND MITRAL VALVE REPLACEMENT SURGERIES Srinivasa Rao Gondi 1, Venkata Sesha Sai Krishna Manne 2 HOW TO CITE THIS ARTICLE: Srinivasa Rao Gondi, Venkata Sesha Sai Krishna
More informationCardiac surgery is associated with a high incidence of
Retrograde Autologous Priming of the Cardiopulmonary Bypass Circuit Reduces Blood Transfusion After Coronary Artery Surgery Subramaniam Balachandran, FRCA, Michael H. Cross, FRCA, Sivagnanam Karthikeyan,
More informationMyocardial enzyme release after standard coronary artery bypass grafting
Cardiopulmonary Support and Physiology Schachner et al Myocardial enzyme release in totally endoscopic coronary artery bypass grafting on the arrested heart Thomas Schachner, MD, a Nikolaos Bonaros, MD,
More informationDoes socio-economic status of patients have an effect on clinical outcomes after coronary artery bypass grafting surgery
ORIGINAL CONTRIBUTION / CLINICAL INVESTIGATION Does socio-economic status of patients have an effect on clinical outcomes after coronary artery bypass grafting surgery Forough Razmjooei (1) Afshin Mansourian
More informationJournal of the American College of Cardiology Vol. 33, No. 6, by the American College of Cardiology ISSN /99/$20.
Journal of the American College of Cardiology Vol. 33, No. 6, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00061-3 for Prediction
More informationIntraoperative haemorrhage and haemostasis. Dr. med. Christian Quadri Capoclinica Anestesia, ORL
Intraoperative haemorrhage and haemostasis Dr. med. Christian Quadri Capoclinica Anestesia, ORL Haemostasis is like love. Everybody talks about it, nobody understands it. JH Levy 2000 Intraoperative Haemorrhage
More informationSafety of Same-Day Coronary Angiography in Patients Undergoing Elective Aortic Valve Replacement
Safety of Same-Day Coronary Angiography in Patients Undergoing Elective Aortic Valve Replacement Kevin L. Greason, MD, Lars Englberger, MD, Rakesh M. Suri, MD, PhD, Soon J. Park, MD, Charanjit S. Rihal,
More informationPBM: The Future of Transfusion December 6 th 2012 East of England RTC. Sue Mallett Royal Free London NHS Foundation Trust
PBM: The Future of Transfusion December 6 th 2012 East of England RTC Sue Mallett Royal Free London NHS Foundation Trust Patient Blood Management The 3 Pillars Pre-operative optimization of anaemia Minimizing
More informationClinical Investigation and Reports. Effectiveness of Coronary Artery Bypass Grafting With or Without Cardiopulmonary Bypass in Overweight Patients
Clinical Investigation and Reports Effectiveness of Coronary Artery Bypass Grafting With or Without Cardiopulmonary Bypass in Overweight Patients Raimondo Ascione, MD; Barnaby C. Reeves, DPhil; Karen Rees,
More informationPredictive Model for Blood Product Use in Coronary Artery Bypass Grafting
ORIGINAL ARTICLE Predictive Model for Blood Product Use in Coronary Artery Bypass Grafting Hasanat Sharif, Hamza Zaheer Ansari, Awais Ashfaq, Wasiq Faraz Rawasia, Gulshan Bano and Shiraz Hashmi ABSTRACT
More informationIs the patient at risk for blood loss of 1000 mls? Avoid these Guidelines. Avoid these Guidelines. Yes. Yes. Yes. Yes. Yes
Clinical Guidelines Acute rmovolemic Hemodilution Guidelines for Cardiac Surgery Department of Anesthesiology and Perioperative Medicine Date: 12-30-2012 Is the patient at risk for blood loss of 1000 mls?
More informationAnalysis of Mortality Within the First Six Months After Coronary Reoperation
Analysis of Mortality Within the First Six Months After Coronary Reoperation Frans M. van Eck, MD, Luc Noyez, MD, PhD, Freek W. A. Verheugt, MD, PhD, and Rene M. H. J. Brouwer, MD, PhD Departments of Thoracic
More informationRetransfusion of Suctioned Blood During Cardiopulmonary Bypass Impairs Hemostasis
Retransfusion of Suctioned Blood During Cardiopulmonary Bypass Impairs Hemostasis Jacob de Haan, Msc, Piet W. Boonstra, MD, PhD, Stefan H. J. Monnink, MD, Tjark Ebels, MD, PhD, and Willem van Oeveren,
More informationTechnique Article. Jeffrey B. Riley;* Gregory J. Schears; Gregory A. Nuttall; William C. Oliver, Jr.; Mark H. Ereth; Joseph A.
The Journal of ExtraCorporeal Technology Technique Article Coagulation Parameter Thresholds Associated with Non-Bleeding in the Eighth Hour of Adult Cardiac Surgical Post-Cardiotomy Extracorporeal Membrane
More informationRisk Factors and Management of Acute Renal Injury in Cardiac Surgery
Risk Factors and Management of Acute Renal Injury in Cardiac Surgery Robert S Kramer, MD, FACS Clinical Associate Professor of Surgery Tufts University School of Medicine Maine Medical Center, Portland
More informationReversal of Anticoagulants at UCDMC
Reversal of Anticoagulants at UCDMC Introduction: Bleeding complications are a common concern with the use of anticoagulant agents. In selected situations, reversing or neutralizing the effects of an anticoagulant
More informationTechnique for Routine Use of Heparin Bonded Circuits with a Reduced Anticoagulation Protocol
Original Article Technique for Routine Use of Heparin Bonded Circuits with a Reduced Anticoagulation Protocol Paul J. O Gara, BS, CCP; Patrick R. Treanor, CCP; Kevin J. Lilly, CCP; Richard F. Crowley,
More informationDisseminated intravascular coagulation (DIC) Dr. Klara Vezendi Szeged University Transfusiology Department
Disseminated intravascular coagulation (DIC) Dr. Klara Vezendi Szeged University Transfusiology Department Disseminated intravascular coagulation (DIC, consumptive coagulopathy) is a clinicopathologic
More information